MIF mediation of sepsis

Nature Medicine

Volumn 6, Issue 2, 2000, Pages 140-141

  Martin, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIAL PERITONITIS; CLINICAL RESEARCH; CYTOKINE PRODUCTION; HUMAN; MEDICAL LITERATURE; MOLECULAR DYNAMICS; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SHORT SURVEY;

ANIMALS; HUMANS; HYDROCORTISONE; INFLAMMATION MEDIATORS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; SEPSIS;

BACTERIA (MICROORGANISMS);

EID: 0033950557     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/72230     Document Type: Short Survey

References (12)

1. Bloom, B.R. & Bennett, B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82 (1966).
2. David, J.R. Delayed hypersensitify in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56, 72-77 (1966).
3. Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 365, 756-759 (1993).
4. Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71 (1995).
5. Weiser, W.Y. et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 86, 7522-7526 (1989).
6. Calandra, T. et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor (MIF). Nature Med. 6, 164-170 (2000).
7. Fowler, A.A., III et al. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98, 593-597 (1983).
8. Montgomery, A.B., Stager, M.A., Carrico, C.J. & Hudson, L.D. Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132, 485-489 (1985).
9. Abraham, E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med. 25, 556-566 (1999).
10. Donnelly, S.C. et al. Regulatory role for macrophage migration inhibitory factor in the acute respiratory distress syndrome. Nature Med. 3, 320-323 (1997).
11. Bernard, G.R. et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818-824 (1994).
12. Hudson, L.D., Milberg, J.A., Anardi, D. & Maunder, R.J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151, 293-301 (1995).